Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PCRX | AMGN | BMY | VRTX | GILD |
| Company | Pacira Pharm Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 17.15 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 17.55 | 290.57 | 58.38 | 455.43 | 89.94 |
| Low | 17.02 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 17.44 | 289.83 | 58.21 | 450.81 | 89.67 |
| Change | +0.41 | +1.96 | +0.33 | -0.42 | +1.04 |
| % Change | +2.41% | +0.68% | +0.57% | -0.09% | +1.17% |
| Volume | 185,879 | 1,476,533 | 3,386,052 | 665,599 | 1,654,464 |
| 20-Day Average Volume | 550,220 | 2,812,064 | 12,180,427 | 1,302,248 | 7,402,926 |
| Previous Close | 17.03 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.95 | 307.39 | 55.92 | 479.27 | 90.89 |
| 20-Day Raw Stochastic | 60.68% | 26.32% | 68.02% | 7.86% | 28.55% |
| 20-Day Relative Strength | 56.49% | 36.13% | 60.45% | 41.06% | 53.54% |
| Weighted Alpha | +2.77 | +1.69 | +25.71 | +18.29 | +26.03 |
| Today's Opinion | 8% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 16% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 40% Sell | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.41% since 11/14/24 | -2.20% since 11/14/24 | -0.66% since 11/14/24 | -6.81% since 11/14/24 | -2.57% since 11/14/24 |
| Low | 16.00 on 11/18/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 17.45 on 11/21/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +0.52% since 10/21/24 | -8.62% since 10/21/24 | +11.50% since 10/21/24 | -5.66% since 10/21/24 | +4.00% since 10/21/24 |
| Low | 16.00 on 11/18/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 18.34 on 11/08/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +25.78% since 08/21/24 | -12.07% since 08/21/24 | +19.97% since 08/21/24 | -7.22% since 08/21/24 | +19.45% since 08/21/24 |
| Low | 12.61 on 09/12/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 18.34 on 11/08/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -43.62% since 05/21/24 | -8.07% since 05/21/24 | +37.49% since 05/21/24 | +2.04% since 05/21/24 | +33.36% since 05/21/24 |
| Low | 11.16 on 08/13/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 31.64 on 06/03/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 786,326 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 46,173 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 674,980,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | 41,960,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 168,570,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -143,470,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.82 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.79 on 11/06/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/06/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 7.27 | 14.57 | 49.77 | 0.00 | 19.81 |